Literature DB >> 29071798

The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.

Haixia Wang1, Youhui Lin1,2, Karin Nienhaus1, G Ulrich Nienhaus1,2,3,4.   

Abstract

Most surfaces of engineered nanoparticles (NPs) are reactive toward biomolecules. Therefore, whenever NPs become immersed in biological fluids, proteins and other biomolecules bind to the NP surface, forming an adsorption layer (biomolecular corona) that modifies the NPs' physicochemical properties and subsequent interactions with living systems. Its exploration is a formidable endeavor owing to the enormous diversity of engineered NPs in terms of their physicochemical properties and the vast number of biomolecules available in biofluids that may bind to NPs with widely different strengths. Significant progress has been made in our understanding of the biomolecular corona, but even very basic issues are still controversially debated. In fact, there are divergent views of its microscopic structure and dynamics, even on physical properties, such as its thickness. As an example, there is no agreement on whether proteins form monolayers or multilayers upon adsorption. In our quantitative studies of NP-protein interactions by in situ fluorescence correlation spectroscopy (FCS) with highly defined model NPs and important serum proteins, we have universally observed protein monolayer formation around NPs under saturation or even oversaturation conditions. Here, we critically discuss biomolecular corona characterization using FCS and dynamic light scattering and identify challenges and future opportunities. Further careful, quantitative experiments are needed to elucidate the mechanisms of biomolecular corona formation and to characterize its structure. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.
© 2017 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2017        PMID: 29071798     DOI: 10.1002/wnan.1500

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  7 in total

1.  Targeted Intravenous Nanoparticle Delivery: Role of Flow and Endothelial Glycocalyx Integrity.

Authors:  Ming J Cheng; Ronodeep Mitra; Chinedu C Okorafor; Alina A Nersesyan; Ian C Harding; Nandita N Bal; Rajiv Kumar; Hanjoong Jo; Srinivas Sridhar; Eno E Ebong
Journal:  Ann Biomed Eng       Date:  2020-02-18       Impact factor: 3.934

2.  Apoptotic and DNA-damaging effects of yttria-stabilized zirconia nanoparticles on human skin epithelial cells.

Authors:  Fatimah Mohammed Alzahrani; Khadijah Mohammed Saleh Katubi; Daoud Ali; Saud Alarifi
Journal:  Int J Nanomedicine       Date:  2019-09-02

Review 3.  Understanding cellular interactions with nanomaterials: towards a rational design of medical nanodevices.

Authors:  Francisca Villanueva-Flores; Andrés Castro-Lugo; Octavio T Ramírez; Laura A Palomares
Journal:  Nanotechnology       Date:  2019-11-26       Impact factor: 3.874

4.  Engineering bioactive surfaces on nanoparticles and their biological interactions.

Authors:  Meghana Matur; Harishkumar Madhyastha; T S Shruthi; Radha Madhyastha; S P Srinivas; P N Navya; Hemant Kumar Daima
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

5.  Sub-10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy.

Authors:  Falco Reissig; Kristof Zarschler; René Hübner; Hans-Jürgen Pietzsch; Klaus Kopka; Constantin Mamat
Journal:  ChemistryOpen       Date:  2020-06-08       Impact factor: 2.911

Review 6.  Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy.

Authors:  Svenja Siemer; Désirée Wünsch; Aya Khamis; Qiang Lu; Arnaud Scherberich; Miriam Filippi; Marie Pierre Krafft; Jan Hagemann; Carsten Weiss; Guo-Bin Ding; Roland H Stauber; Alena Gribko
Journal:  Nanomaterials (Basel)       Date:  2020-02-22       Impact factor: 5.076

7.  Silver-doped graphene oxide nanocomposite triggers cytotoxicity and apoptosis in human hepatic normal and carcinoma cells.

Authors:  Daoud Ali; Saud Alarifi; Saad Alkahtani; Rafa S Almeer
Journal:  Int J Nanomedicine       Date:  2018-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.